Abstract
A novel coronavirus (2019-nCov) has wreak havoc across the globe, especially in the USA, Italy, Spain, France, Iran, UK, and China. The coronavirus infection has caused a pandemic (COVID-19), which is an acute infectious pneumonia of the 21st Century. 2019-nCov, being novel in nature has brought the world to a standstill and forced a global health emergency, which is attributed to the unavailability of viable antiviral drug, and the only options left are supportive care and non-specific treatment to improve the symptomatic conditions of patients. But still, it is not a permanent solution and there is a need to find an effective antiviral drug. The earlier reported SARS-CoV and recently emerged SARS-CoV-2 have similar homology in terms of epidemiology, genomics and pathogenesis, and it has been observed that the SARS-CoV was contained by Traditional Chinese Medicine (TCM). Thus, this review summarizes the information on natural traditional medicine, including Indian Ayurvedic Medicine and TCM having antiviral potential which have been used to control earlier pandemics, and their candidacy for the new drug development to control the COVID-19. In the wake of the current unprecedented situation, it is imperative to find effective and novel anti-SARS-CoV-2 agents by exploring traditional medicine which would be highly precise in action with minimal side effects.
Keywords: Traditional medicine, COVID-19, SARS-CoV-2, antiviral, ayurvedic medicine, chinese medicine, pandemic.
Current Traditional Medicine
Title:Traditional Medicine - A Possible Stop Codon for COVID-19
Volume: 7 Issue: 4
Author(s): Nissar A. Reshi, Anup S. Deshpande, Namita A. Raytekar and Vasudeo P. Zambare*
Affiliation:
- Department of Life Sciences, School of Science, Sandip University, Nashik, Maharashtra,India
Keywords: Traditional medicine, COVID-19, SARS-CoV-2, antiviral, ayurvedic medicine, chinese medicine, pandemic.
Abstract: A novel coronavirus (2019-nCov) has wreak havoc across the globe, especially in the USA, Italy, Spain, France, Iran, UK, and China. The coronavirus infection has caused a pandemic (COVID-19), which is an acute infectious pneumonia of the 21st Century. 2019-nCov, being novel in nature has brought the world to a standstill and forced a global health emergency, which is attributed to the unavailability of viable antiviral drug, and the only options left are supportive care and non-specific treatment to improve the symptomatic conditions of patients. But still, it is not a permanent solution and there is a need to find an effective antiviral drug. The earlier reported SARS-CoV and recently emerged SARS-CoV-2 have similar homology in terms of epidemiology, genomics and pathogenesis, and it has been observed that the SARS-CoV was contained by Traditional Chinese Medicine (TCM). Thus, this review summarizes the information on natural traditional medicine, including Indian Ayurvedic Medicine and TCM having antiviral potential which have been used to control earlier pandemics, and their candidacy for the new drug development to control the COVID-19. In the wake of the current unprecedented situation, it is imperative to find effective and novel anti-SARS-CoV-2 agents by exploring traditional medicine which would be highly precise in action with minimal side effects.
Export Options
About this article
Cite this article as:
Reshi A. Nissar, Deshpande S. Anup , Raytekar A. Namita and Zambare P. Vasudeo *, Traditional Medicine - A Possible Stop Codon for COVID-19, Current Traditional Medicine 2021; 7 (4) . https://dx.doi.org/10.2174/2215083806999201130103521
DOI https://dx.doi.org/10.2174/2215083806999201130103521 |
Print ISSN 2215-0838 |
Publisher Name Bentham Science Publisher |
Online ISSN 2215-0846 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel Corona-Virus Disease 2019 (COVID-19): A Perilous Life- Threatening Epidemic
Coronaviruses COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development
Pharmaceutical Nanotechnology Anti-malarial Drugs are Not Created Equal for SARS-CoV-2 Treatment: A Computational Analysis Evidence
Current Pharmaceutical Design Discovery of Potential Inhibitors of the Receptor-binding Domain (RBD) of Pandemic Disease-causing SARS-CoV-2 Spike Glycoprotein from Triphala Through Molecular Docking
Current Chinese Chemistry Exploitation of Some Natural Products for the Prevention and/or Nutritional Treatment of SARS-CoV2 Infection
Endocrine, Metabolic & Immune Disorders - Drug Targets Place of Nanofiltration for Assuring Viral Safety of Biologicals
Current Nanoscience Natural Products as Anti-COVID-19 Agents: An <i>In Silico</i> Study
Coronaviruses Mental Health Problems Experienced by Patients with Rheumatic Diseases During COVID-19 Pandemic
Current Rheumatology Reviews A Brief Outlook on Possible Available Solutions, Therapies and Suggestions for COVID-19
Coronaviruses Role of key point Mutations in Receptor Binding Domain of SARS-CoV-2 Spike Glycoprotein
Infectious Disorders - Drug Targets Impact and Inescapable Effects of Coronavirus: History to Modern Pandemic Episode
Coronaviruses Engineering Novel Anticoagulant Proteins by Motif Grafting
Protein & Peptide Letters SARS-CoV-2: Origin, Pathogenesis and Therapeutic Interventions
Coronaviruses Chemistry and Pharmacology of Natural Catechins from <i>Camellia sinensis</i> as Anti-MRSA Agents
Current Topics in Medicinal Chemistry Thoughts of Death, Depression and Guilt in a Healthcare Worker Who Infected Her Husband with SARS-CoV-2: A Case Report
CNS & Neurological Disorders - Drug Targets COVID-19: Small-Molecule Clinical Trials Landscape
Current Topics in Medicinal Chemistry Study of SARS-nCoV2 Indian Isolates Gaining Insights into Mutation Frequencies, Protein Stability and Prospective Effect on Pathogenicity
Coronaviruses A Tour of Unsupervised Deep Learning for Medical Image Analysis
Current Medical Imaging In-silico Study to Identify Dietary Molecules as Potential SARS-CoV-2 Agents
Letters in Drug Design & Discovery In silico Study to Evaluate the Antiviral Activity of Novel Structures against 3C-like Protease of Novel Coronavirus (COVID-19) and SARS-CoV
Medicinal Chemistry